CalciMedica is trading 5.49% higher in pre-market at $1.73 on November 2; available reporting does not identify a company-specific catalyst.
- Shares closed at $1.46 on October 30 after a 16.57% decline.
- A pre-market movers report noted a gain after Friday’s drop but did not identify a company-specific catalyst.
- CalciMedica’s investor-relations page lists September 8 as its latest press release, with no November 2 announcement shown. The broader market is modestly positive, but evidence does not establish it as the cause of this move.